wpe1B1.jpg (1915 bytes) TigerSoft Blog www.tigersoftware.com
                   See www.tigersoft.com  Contact   william_schmidt@hotmail.com     858-273-5900
                       since June 1010

wpeC140.jpg (3953 bytes)    WHERE TO GO FIRST FOR
                  BIOTECH JOBS IN SAN DIEGO

                              3/26/2011   (C) 2011 Wm.Schmidt, Ph.D.

                             We look back to June 30th, 2010 to measure the performance of
                            San Diego's stocks to see if we can help some people we know
                            get a new job.  We start at the last  "reversing" buy signal from our
                            Peerless Stock Market Timing system.   There has not been a major
                            market sell since then; the  DJI has risen more than 25% in this
                            period.   San Diego's companies' stocks are mostly lagging, but
                            the ones that are not are definitely better prospects for finding a
                            job than the ones whose stocks are falling.

                                   Stock investors, read our TigerSoft and Peerless documentation 
                            on using our Insider Trading Charts with automatic Buys and Sells.
                             how to start using it at www.tigersoft.com

                                              PEERLESS BUYS/SELLS on DJIA
wpe1B4.jpg (58716 bytes)
(C) 2011   William Schmidt, Ph.D.  www.tigersoft.com    3/25/2011

We recommend looking at the stocks in your area if you are looking for a job.  The
                 stocks that are going up tend to be companies that are expanding and hiring.  We also
                 suggest you show your interviewer our TigerSoft chart of their company.  They will
                 probably be interested in the buys and sells   it shows the optimum trading system
                 They will be intrigued at how professional traders whip the stock up and down.  They
                 will be also want to know whether the stock shows Insider Buying or Selling
                 (See Tiger Accumulation Index) and Professional Buying or Selling (See Tiger Closing Power).  
                 These lie at the heart of our Tiger trading tools.  See our discussion of how
                 we measure insider buying. "

wpe1B2.jpg (47660 bytes)
wpe1B3.jpg (4605 bytes)

  Wall Street versus Main Street
   San Diego's stocks are underperforming the much watched Dow Jones Industrial
                 Average.   Wall Street's blue chips are doing much better than Main Street's smaller
                 companies.   See this in the chart below. There have been many criticisms lodged
                 against Wall Street and Washington for subsidizing the very rich, big Wall Street banks
                 and the biggest multinational corporations while largely neglecting the rest of America,
                 the poor, the unemployed. 

US experiencing uneven job growth across states

                     The Tiger Index of San Diego Stocks is an index, where companies are weighted by
                 the trading value of their stocks.  As you can see above,  San Diego's recovery as viewed by this
                 Tiger index is lagging badly and not even making yearly new highs as the Dow Jones Industrial
                 Average is.  The DJI is up 25% since last June.  Only 16 of the 56 San Diego stocks we have
                 studied are up this much.  See the table below.

                     "Where is the bailout for Main Street? Where are the jobs?", Washington policy makers.
                 How long must Americans wait for private sector jobs?  Clearly the rich need to be taxed
                 a lot more, as they were until Reagan and public sector jobs must be created to fill the
                 job gap.  Unfortunately, the most Democrats are every bit as bad as Republicans.  We argue
                 that Obama has made a deal with Wall Street and Bernanke of the Fed to run up stock prices
                 for their campaign contributions next year, but the "trickle down" is barely felt here.  I have
                 been saying this was the best reason to buy stocks since March 2009.  But it has not helped
                 create jobs very much.  Manufacturing jobs are being sent overseas with the tax subsidized
                 bailouts for banks, brokerages and the big multinational companies that make up the Dow

                 Jones average. 

Of course, San Diego will always attract tourists and refugees from cold weather.  That
                 helps hold up the real estate market and local banks.  But good paying jobs, as in
                 manufacturing and biotech, are not sufficient for the well educated population here.
                 Military suppliers, credit enforcers, banks, oil investing firms and data storage providers
                 each have representation in the top performing stocks of San Diego.  Biotechs appear
                 most often, reflecting the number of such companies here. 

                      If you are a San Diego job seeker, always first look at the companies whose stocks
                 are doing the best.  Print out the charts of the best performing stocks here.  And go to these
                 companies' employment offices.   If you want to learn about trading, talk to us and come to
                 our free monthly seminars for Tiger  Users.   We always are looking for salespeople, too. 
                 And we pay a hefty finders fee to users who get us new Tiger users.

     wpe1B5.jpg (6582 bytes)   
      Insider Trading is Rampant Tiger Soft Insider Trading Charts Trade with the Pros.
           Tiger Power Stock Ranker       Explosive Super Stocks    Killer Short Sales   Tahiti DJIA-30 System 

                           Use TigerSoft's Insider Trading Charts To Look Beneath A Stock's Surface  


                      Most important, look for the company's chart below for evidence of insider buying, as
                 TigerSoft measures it and are up at least as much as DJIA.  See in charts below those cases
                 where Accumulation Index rises above the critical threshold.  If insiders are buying, the chances
                 are good they believe the company has a good future.  If the Blue Closing Power agrees, the
                 stock must also rise.

CYMI Cytori Therapeutics, Inc. 3020 Callan Road  San Diego, CA 92121  - Map
                        Phone: 858-458-0900  Fax: 858-458-0994  Website: http://www.cytoritx.com  

SNMX Senomyx Inc. 4767 Nexus Centre Drive San Diego, CA 92121  - Map
                        Phone: 858-646-8300  Fax: 858-404-0752  Website: http://www.senomyx.com

                        ACAD ACADIA Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard  San Diego, CA 92121   Map
                        Phone: 858-558-2871  Fax: 858-558-2872 Website: http://www.acadia-pharm.com   27 employees

                        GPRO   Gen-Probe Inc.   10210 Genetic Center Drive San Diego, CA 92121   - Map
                        Phone: 858-410-8000  Fax: 858-410-8625 Website: http://www.gen-probe.com

DRAD Digirad Corporation 3950 Stowe Drive Poway, CA 92064-8803   - Map
                        Phone: 858-726-1600  Fax: 858-726-1700  Website: http://www.digirad.com  

ACCL Accelrys Inc. 10188 Telesis Court Suite 100 San Diego, CA 92121   - Map
                        Phone: 858-799-5000   Fax: 858-799-5100

                    SAN DIEGO STOCKS'
           Performance based on 185 Days back.
                    6 / 30 / 2010 - 3 / 25 / 2011 

Rank          Symbol        Name                        Price          Pct.Gain     
---------     -----------------------------------       ----------    ------------   
 1            ROYL          ROYALE ENERGY INC            5.32          167%           
Royale Energy, Inc. operates as an independent oil and natural gas producer in the United States.
22 employees. 7676 Hazard Center Drive Suite 1500 San Diego, CA 92108
Phone: 619-881-2800 Website: http://www.royl.com

 2            CYTX          Cytori Therapeutics          7.57          117%
Cytori Therapeutics, Inc.
3020 Callan Road
San Diego, CA 92121
United States - Map
Phone: 858-458-0900
Fax: 858-458-0994
Website: http://www.cytoritx.com  number of employees not available

Cytori Therapeutics, Inc. engages in the development, manufacture, and 
sale of medical technologies to enable the practice of regenerative 
medicine. Regenerative medicines focus on repairing or restoring lost 
or damaged tissue and cell function. The company develops its product 
pipeline for the treatments of cardiovascular disease, spinal disc 
degeneration, gastrointestinal disorders, liver and renal disease, 
and pelvic health conditions. Its principal products include the 
Celution family of products, which processes patients' adipose-derived 
stem and regenerative cells (ADRCs) at the point of care. The Celution 
family of products consists of a central device, a related single-use 
consumable used for each patient procedure, proprietary enzymes, and 
related instrumentation. Its core product, the Celution System, 
provides physicians with clinical grade stem and regenerative cells 
for use in the cosmetic and reconstructive surgery market. It also 
intends to offer the PureGraft System in the U.S as a medical device 
that prepares autologous fat grafts for use in aesthetic body contouring. 
The company also sells the StemSource family of products worldwide, 
including in the United States, for research, as well as for the 
cryopreservation and storage of ADRCs. It offers the StemSource System 
as a standalone product, or as a part of a comprehensive suite of 
systems, equipment, and protocols collectively referred to as a 
StemSource Cell Bank. The company also develops Celution System for 
applications in cardiovascular disease, wound healing, gastrointestinal 
disorders, stress urinary incontinence, liver and renal disease 
spinal disc degeneration, and pelvic health conditions.

CYTX.BMP (1920054 bytes)

 3            HILL          Dot Hill Systems Corp.       2.4           101%         - 
Dot Hill Systems Corp.
1351 South Sunset Street
Suite 100
Longmont, CO 80501-6533
United States - Map
Phone: 303-845-3200
Fax: 303-845-3365
Website: http://www.dothill.com   293 employees

Dot Hill Systems Corp. provides entry-level and midrange storage systems 
and enterprise server software for organizations requiring networked 
storage and data management solutions in open systems architecture.
 4            CYMI          CYMER INC.	                 54.83         82%           
Cymer Inc.
17075 Thornmint Court
San Diego, CA 92127
United States - Map
Phone: 858-385-7300
Fax: 858-385-7100
Website: http://www.cymer.com  953 employees
Cymer, Inc., together with its subsidiaries, engages in the development, 
manufacture, and marketing of excimer light sources for the manufacturers 
of photolithography tools in the semiconductor equipment industry.
CYMI.BMP (1920054 bytes)

 5            CDFB          CORONADO FIRDT BANK          5.15          80%  
 Coronado First Bank
801 Orange Avenue
Suite 101
Coronado, CA 92118
United States - Map
Phone: 619-437-1000
Fax: 619-437-1070
Website: http://www.coronadofirst.com        
 6            QCOM          QUALCOMM INCORPOR            52.75         60%          
QUALCOMM Incorporated
5775 Morehouse Drive
San Diego, CA 92121-1714
United States - Map
Phone: 858-587-1121
Fax: 858-658-2100
Website: http://www.qualcomm.com  17,500 employees

 7            SNMX          Senomyx Inc.                 6.05          59%          
Senomyx Inc.
4767 Nexus Centre Drive
San Diego, CA 92121
United States - Map
Phone: 858-646-8300
Fax: 858-404-0752
Website: http://www.senomyx.com   108 employees
Senomyx, Inc. engages in the discovery and development of flavor 
ingredients in the savory, sweet, salt, bitter, and cooling areas 
using proprietary taste receptor technologies. The company has 
product discovery, development, and commercialization collaborations 
with seven food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is marketing products that contain one of Senomyx?s flavor ingredients. 

SNMX.BMP (1920054 bytes)

 8            CUB           CUBIC CP	                 56.31         54%        
Cubic Corporation
9333 Balboa Avenue
San Diego, CA 92123
United States - Map
Phone: 858-277-6780
Fax: 858-277-1878
Website: http://www.cubic.com  7700 employees

Cubic Corporation designs, develops, manufactures, and installs 
military electronics and transportation fare collection systems. 
Its Mission Support Services segment provides live, virtual, and 
constructive training services for the U.S. and allied militaries, 
as well as force modernization, battle command training, professional 
military education, leader development, intelligence systems training, 
open-source analysis, operations and maintenance support, logistics 
support, and weapons effects modeling services. 

 9            RFIL          RF INDUSTRIES LTD            4.05          53%        
RF Industries Ltd.
7610 Miramar Road
Suite 6000
San Diego, CA 92126-4202
United States - Map
Phone: 858-549-6340
Fax: 858-549-6345
Website: http://www.rfindustries.com       110 employees

RF Industries, Ltd. provides interconnect products and systems for 
radio frequency (RF) communications devices and wireless digital 
transmission systems in the United States and internationally. 
Its Connector and Cable Assembly division designs, manufactures, 
and distributes coaxial connectors and cable assemblies. The company's 
Aviel Electronics division engages in the design, manufacture, 
and distribution of specialty and custom RF connectors primarily 
for aerospace and military customers.

RFIL.BMP (1920054 bytes)
 10           ILMN          Illumina Inc.                65.45         50% 
Illumina Inc.
9885 Towne Centre Drive
San Diego, CA 92121
United States - Map
Phone: 858-202-4500
Fax: 858-587-4297
Website: http://www.illumina.com    2100 employees
llumina, Inc. develops, manufactures, and markets integrated systems 
for the analysis of genetic variation and biological function. Its 
instrumentation products include HiSeq 2000, an instrument for 
high-throughput (up to 200 Gb per run and up to 25 GB per day) 
sequencing using sequencing-by-synthesis (SBS) technology; 
Genome Analyzer IIx, an instrument for medium to high-throughput 
(up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer 
IIe, an instrument for low to medium throughput (up to 40 Gb per run) 
sequencing using SBS technology; iScan System, a high-resolution 
imaging instrument to scan BeadArray based assays; and BeadXpress Reader,
a low- to mid-multiplex, high-throughput instrument for readout of assays.
The company?s consumables consist of InfiniumHD Whole-Genome BeadChips 
comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, 
which are multi-sample DNA analysis microarrays; iSelect Custom 
Genotyping BeadChips that are customer designable SNP genotyping 
arrays; GoldenGate Assay Method, a high throughput assay and 
genotyping system; GoldenGate Universal-32 Sample BeadChip, 
which are 32 sample GoldenGate genotyping arrays; Paired-End 
Genomic DNA Sample Prep Kit, a streamlined library preparation 
kit to generate 200?500 kb insert paired-end reads; VeraCode 
GoldenGate that are low plex GoldenGate genotyping arrays compatible 
with the BeadXpress System; Standard Sequencing Kit, reagents used 
for SBS chemistry on sequencing platforms; and Infinium Assay Kit, 
reagents used to perform Infinium assays on the iScan platform. It 
also provides sequencing and genotyping services.

ILMN.BMP (1920054 bytes)
 11           ACAD          Acadia Pharmaceuticals Inc.  1.62          48%       
ACADIA Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego, CA 92121
United States - Map
Phone: 858-558-2871
Fax: 858-558-2872
Website: http://www.acadia-pharm.com  27 employees
ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, 
focuses on drug discovery and clinical development of novel 
treatments for central nervous system disorders. The company 
has a portfolio of four product candidates, including pimavanserin, 
which is in Phase III clinical development as a treatment for 
Parkinson's disease psychosis. It is also developing AGN XX/YY, 
a product candidate in Phase II for chronic pain; and AC-262271, 
a product candidate in Phase I for glaucoma, both in collaboration 
with Allergan, as well as AM-831, a product candidate in IND-track 
development for schizophrenia in collaboration with Meiji Seika Kaisha. 
The product candidates in the company?s pipeline emanate from 
discoveries made using its proprietary drug discovery platform.

ACAD.BMP (1920054 bytes)
 12           PSMT          PRICESMART INC.	         34.57         48%
 13           MXWL          MAXWELL TECHNOLOG            16.77         47%
Maxwell Technologies Inc.
5271 Viewridge Court
Suite 100
San Diego, CA 92123
United States - Map
Phone: 858-503-3200
Fax: 858-503-3301
Website: http://www.maxwell.com  314 employees
Maxwell Technologies, Inc. develops, manufactures, and markets 
energy storage and power delivery products, and microelectronic 

MXWL.BMP (1920054 bytes)
 14           AVNR          AVANIR PHARMACEUT            3.77          46%
AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and 
commercializing novel therapeutic products for the treatment of 
central nervous system disorders primarily in the United States 
and Canada. Its lead product candidate includes Zenviatm, which 
has completed three Phase III clinical trials for the treatment of 
pseudobulbar affect; and a Phase III trial for the treatment of 
patients with diabetic peripheral neuropathic pain.

Avanir Pharmaceuticals
101 Enterprise
Suite 300
Aliso Viejo, CA 92656
United States - Map
Phone: 949-389-6700
Website: http://www.avanir.com   128 employees
AVNR.BMP (1920054 bytes)

 15           GPRO          Gen-Probe Inc.               65.31         43% 
Gen-Probe Inc.
10210 Genetic Center Drive
San Diego, CA 92121
United States - Map
Phone: 858-410-8000
Fax: 858-410-8625
Website: http://www.gen-probe.com  1363 employees
Gen-Probe Incorporated engages in the development, manufacture, 
and marketing of nucleic acid tests used primarily to diagnose human 
diseases and screen donated human blood in North America and 
internationally. The company markets a portfolio of products to 
detect infectious microorganisms, including those causing sexually 
transmitted diseases, tuberculosis, strep throat, and other infections. 
Its primarily product line includes APTIMA Combo 2 assay, APTIMA CT, 
APTIMA GC assays, and PACE family of assays to detect chlamydia and 
gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV 
assay to detect 14 sub-types of high-risk HPV associated with 
cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to 
detect GBS from culture. The company?s product line also include APTIMA 
HIV-1 assay to detect RNA from HIV-1, the virus that causes AIDS; APTIMA
HCV assay to detect RNA from the hepatitis C virus; and ASRs for 
quantitative HCV testing to quantify HCV viral load. It also offers 
Pro-Flu+, Pro-Flu ST, ProGastro Cd, AMPLIFIED MTD, and GAS Direct 
for various respiratory infectious diseases; LIFECODES HLA DNA typing 
kits and LIFECODES LifeScreen antibody screening kits in the transplant 
diagnostics field; Procleix HIV-1/HCV assay, Procleix Ultrio assay, 
Procleix Ultrio Plus assay, and Procleix WNV assay for the blood 
donor screening market; and TIGRIS and Direct Tube Sampling instrument 
systems to develop instrumentation. In addition, the company?s 
developing products include PANTHER, an automated testing instrument. 
Further, the company offers PROGENSA PCA3 and PCA3 ASRs to detect the 
PCA3 gene. The company?s customers include reference laboratories, 
public health institutions, and hospitals.
GPRO.BMP (1920054 bytes)
 16           RDEA          ARDEA BIOSCIENCES            27.93         35%
Ardea Biosciences, Inc.
4939 Directors Place
San Diego, CA 92121
United States - Map
Phone: 858-652-6500
Fax: 858-652-0760
Website: http://www.ardeabiosciences.com   number of employees - unknown
rdea Biosciences, Inc., a biotechnology company, focuses on the 
discovery and development of small-molecule therapeutics for the 
treatment of gout, human immunodeficiency virus (HIV), and cancer 
in the United States. The company?s products include RDEA594, a 
Phase IIb clinical trial product for the treatment of gout; RDEA684, 
a preclinical trial product for the treatment of gout with 
hyperuricemia; RDEA806, a non-nucleoside reverse transcriptase 
inhibitor, which completed Phase II clinical trial for the treatment 
of patients with HIV; and RDEA427, which is in first-in-human micro-dose 
pharmacokinetic study for the treatment of HIV infection. It is 
evaluating RDEA119, an inhibitor of Mitogen-activated ERK kinase (MEK), 
which is in Phase I/II study in combination with sorafenib and as a 
single agent in a Phase I study, both in advanced cancer patients. 
The company has a license agreement with Bayer to develop and 
commercialize MEK inhibitors for various indications. 
RDEA.BMP (1920054 bytes)
 17           SNTS          Santarus Inc.                3.28          32% 
Santarus Inc.
3721 Valley Centre Drive
4th Floor
San Diego, CA 92130
United States - Map
Phone: 858-314-5700
Fax: 858-314-5701
Website: http://www.santarus.com   335 employees
Santarus, Inc., a specialty biopharmaceutical company, engages in 
acquiring, developing, and commercializing proprietary products 
that address the needs of patients treated by physician specialists. 
The company commercializes CYCLOSET (bromocriptine mesylate) tablets, 
and focuses to commercialize GLUMETZA (metformin hydrochloride 
extended release tablets) that are indicated as adjuncts to diet 
and exercise to improve glycemic control in adults with type 
2 diabetes. It also has a development pipeline with three late-stage 
product candidates in Phase III clinical programs, including ULTESA (
budesonide MMX) for induction of remission of active ulcerative colitis, 
rifamycin SV MMX for treatment of travelers? diarrhea, and RHUCIN 
(recombinant human C1 inhibitor) for the treatment of acute attacks 
of hereditary angioedema. In addition, Santarus plans to initiate a
Phase I clinical study for SAN-300, an anti-VLA-1 antibody development 
compound that it expects to develop for the treatment of rheumatoid 
SNTS.BMP (1920054 bytes)
 18           DXCM          DexCom                       14.64         26%
DexCom, Inc.
6340 Sequence Drive
San Diego, CA 92121
United States - Map
Phone: 858-200-0200
Fax: 858-200-0201
Website: http://www.dexcom.com   405 employees
DexCom, Inc., a medical device company, focuses on the design, 
development, and commercialization of continuous glucose monitoring 
systems for ambulatory use by people with diabetes, and for use by 
healthcare providers in the hospital for the treatment of both diabetic 
and non-diabetic patients. The company offers FDA approved SEVEN, 
which includes a disposable sensor that can be inserted by a patient 
and used continuously for up to seven days; a transmitter; and a small 
handheld receiver. Its SEVEN system also received CE Mark approval 
for commercialization in the European Union and the countries in 
Asia and Latin America that recognize the CE Mark. The company also 
provides the SEVEN PLUS, which incorporates additional user interface 
and algorithm enhancements that are intended to make its glucose 
monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark 
approvals. DexCom has a collaboration agreement with Edwards Lifesciences 
LLC to develop products for continuously monitoring blood glucose 
levels in patients hospitalized for various conditions. It also has 
development agreement with Insulet Corporation to integrate its 
continuous glucose monitoring technology into Insulet?s wireless, 
handheld OmniPod System Personal Diabetes Manager; and a joint 
development agreement with Animas Corporation to integrate its 
continuous glucose monitoring technology into Animas insulin pumps.
 19           DRAD          Digirad Corp.                2.58          24% 
Digirad Corporation
13950 Stowe Drive
Poway, CA 92064-8803
United States - Map
Phone: 858-726-1600
Fax: 858-726-1700
Website: http://www.digirad.com   349 employees
The company operates in two segments, Digirad Imaging Solutions 
and Product. The Digirad Imaging Solutions segment offers various 
personnel and equipment leasing services for physicians to perform 
nuclear imaging, echocardiography, vascular ultrasound, or any 
combination of these procedures in their offices by leasing the 
imaging system, certified personnel, and other support required 
to perform imaging. This segment primarily serves cardiologists and 

DRAD.BMP (1920054 bytes) 
 20           ECPG          Encore Capital Group Inc.    25.63         24% 
http://www.encorecapitalgroup.com  1891 employees
purchases and manages charged-off consumer receivable portfolios. 
Its receivable portfolios include unsecured, charged-off domestic 
consumer credit cards, auto loan deficiency, and telecom receivables 
purchased from national financial institutions, major retail 
credit corporations, telecom companies, and resellers.
 21           WDFC          WD-40 COMPANY                41.64         24% 
 22           NBIX          NEUROCRINE BIOSCI            6.79          21% 
Neurocrine Biosciences Inc.
12780 El Camino Real
San Diego, CA 92130
United States - Map
Phone: 858-617-7600
Fax: 858-617-7601
Website: http://www.neurocrine.com  66 employees
Neurocrine Biosciences, Inc. engages in the discovery, development, 
and commercialization of drugs for the treatment of neurological and 
endocrine-related diseases and disorders in the United States. 
It develops drugs for endometriosis, anxiety, depression, pain, 
diabetes, irritable bowel syndrome, insomnia, and other neurological 
and endocrine-related diseases and disorders. Its products in clinical 
development include Elagolix, a phase II product for endometriosis; 
CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide 
Agonist, a phase II drug for cardiovascular diseases; CRF1 Antagonist, 
a phase I product for treating mood disorders and irritable bowel 
syndrome; Vesicular Monoamine Transporter 2 Inhibitor, a phase I 
product for movement disorders and schizophrenia; and Elagolix, 
a phase I product for uterine fibroids, and men?s and women?s health. 
The company?s research programs comprise Glucose Dependent Insulin 
Secretagogues for type II diabetes; Antiepileptic Drugs for epilepsy 
and bipolar disorder; and GnRH Antagonists for hormone dependent 
diseases and oncology. Its product pipeline also includes Indiplon
5mg and 10mg capsules, the FDA deemed approvable products, for 
the treatment of insomnia.

NBIX.BMP (1920054 bytes)
 23           SHW           SHERWIN WILLIAMS             83.85         21%            
 24           VSAT          VIASAT INC.	                 39.46         21% 
ViaSat Inc.
6155 El Camino Real
Carlsbad, CA 92009
United States - Map
Phone: 760-476-2200
Fax: 760-929-3941
Website: http://www.viasat.com   2000 employees
ViaSat, Inc. engages in the design, production, and marketing of 
satellite and other wireless communication, and networking systems 
for government and commercial customers. 
 25           COHU          COHU INC.	                 14.67         20%      
 26           WBSN          Websense Inc.                22.83         20%         
 27           ACCL          Accelrys Inc.                7.64          18% 
Accelrys Inc.
10188 Telesis Court
Suite 100
San Diego, CA 92121
United States - Map
Phone: 858-799-5000
Fax: 858-799-5100
Website: http://www.accelrys.com   number of employees - not known

Accelrys, Inc. engages in the design, development, marketing, 
and support of software based solutions that facilitate the 
discovery and development of products and processes in the 
pharmaceutical, biotechnology, energy, chemicals, aerospace, 
and consumer packaged goods industries worldwide. The company 
offers scientific informatics platform, which allows users to 
aggregate, integrate, and mine the quantities of structured and 
unstructured scientific data, such as chemical structures, 
biological sequences, and digital images, as well as filters, 
normalizes, and performs statistical analysis on scientific data and 
provides interactive visual reports to scientists and scientific managers.
 It also provides computer aided design modeling and simulation 
software that allows scientists to perform computations of chemical, 
biological, and materials properties to simulate, visualize, and 
analyze chemical and biological systems, as well as to communicate 
the results to other scientists; and cheminformatics software, 
which is designed to capture, store, manage, and mine chemical 
information. In addition, the company offers a range of solutions
from software wrappers that allows customers to run their own 
algorithms on scientific informatics platform to enterprise-wide 
informatics systems, which integrate customers? internal systems 
with software from various vendors; contract research services; 
onsite training and implementation services, Web-based training, 
and data migration services; and support services. 
ACCL.BMP (1920054 bytes)
 28           OVRL          OVERLAND STORAGE             2.4           18%   
 29           LEAP          LEAP WIRELESS INT            15.02         15%    
 30           BMR           BioMed Realty Trust Inc.     18.45         14% 
 31           ELY           CALLAWAY GOLF CP	         6.89          14%      
 32           O             REALTY INCOME CP	         34.62         14%             
 33           LGND          LIGAND PHARMACEUT            10.29         13%            
 34           SRE           SEMPRA ENERGY	         52.49         12%           
 35           AHS           AMN HEALTHCARE SV            8.21          9% 
 36           INO           Inovio Biomedical Corp.      1.12          9%            
 37           BOFI          BofI Holding                 15.27         8%             
 38           ALDA          ALDILA INC.	                 4.3           7%           
 39           SQNM          Sequenom Inc.                6.07          2%  
                 The stocks below show losses.
 40           SAI           SAIC INC	                 16.68        -1%         
 41           RMD           ResMed Inc.                  30.05        -2%               
 42           PICO          PICO Holdings  29.01         -4%          -3.8%            
 43           NVTL          Novatel Wireless Inc.        5.36         -7%             
 44           QDEL          QUIDEL CORPORATIO            11.85        -7%                   
 45           ISIS          ISIS Pharmaceuticals Inc.    8.74         -9%                  
 46           MITI          MICROMET INC.	         5.48         -13%       
 47           VICL          VICAL INCORPORATE            2.5          -20%            
 48           SOMX          Somaxon Pharmaceuticals      2.77         -24%                 
 49           TNXI          Telanetix                   .038         -24%              
 50           NUVA          NuVasive                     25.2         -29%                
 51           PURE          PURE BIOSCIENCE	         1.61         -33%                
 52           LJPC          LA JOLLA PHARMACE            .028         -40%                   
 53           XNN           Xenonics HoldingsAHS         .21          -40%                     
 54           ANDS          Anadys Pharmaceuticals Inc.  1.14         -41% 
ANDS.BMP (1920054 bytes)          
 55           AMLN          Amylin Pharmaceuticals Inc.  10.54        -44%           
 56           ARNA          Arena Pharmaceuticals Inc.   1.45         -53%
ARNA.BMP (1920054 bytes)